Skip to main content
OpenTrials
Completed

NCT Number: NCT04721938

Healthy Parents - Healthy Children. Weight Loss Before Fertility Treatment

The detrimental effect of overweight and obesity on fecundity has been well documented.

The investigators wish to investigate the intervention program for weight loss before fertility treatment.

Subsequently to gain knowledge on the effect of overweight/obesity and weight loss on the vaginal microbiome, on DNA damage on sperm cells, on the occurrence of endocrine disruptors in the endometrium, and on the gene expression in the endometrium.

Completed

Looking for future studies?

Notify Me

Key information

About this study

Purpose and aim of the study The Fertility Clinic at Zealand University Hospital wishes to introduce a new care concept: 'Healthy Parents - Healthy Children´ with the purpose of changing the behaviours of infertile men and women towards a healthier life style now and for future generations.

The Zealand Region includes areas of significant deprivation compared to Copenhagen and has a higher prevalence of obesity and poor diet.

These inequalities generate socio-demographic and long-term health challenges, decrease the chance of becoming pregnant and increase risk of life style related diseases for parents and their offspring in the long term.

The waiting time before fertility treatment (12 months in the region) represents a unique window of opportunity to encourage long-term life style changes. The aforementioned reasons initiated the planned Preconception Clinic 'Healthy Parents - Healthy Children´.

The Preconception Clinic utilises waiting list time to optimise parental health prior to conception. We will provide weight loss interventions aimed at helping the patients to a healthier lifestyle, an increased chance of conception and a decreased risk of life style diseases for themselves and their future offspring.

Purpose of study:

Patient weight loss of at least 10% at the end of intervention and at annular follow up until 5 years.

Study population: Sub-fertile population referred to the Fertility Clinic Region Zealand due to infertility.

Inclusion criteria

20 women and 20 men with a BMI>30, age 18-40 years.

Exclusion criteria

Inability to understand the written and oral information.

Baseline and end of intervention-sampling:

  • Blood tests (metabolic markers), blood tests for Biobank and for miRNA biomarkers
  • Urine sample
  • Women: Endometrial biopsy and vaginal swab for microbiome testing
  • Men: Sperm sample

Intervention: Weight reduction through life style changes in diet and exercise by the following means:

  • Counselling with a Nutritionist Nurse on diet and exercise.
  • Online smartphone coaching program (LifeSum-App)
  • Motivational and adjustment dialogue and counselling with Nutritionist Nurse including anthropometric measures every month.

Primary endpoint: Weight loss of at least 10%.

Anticipated impact The aim of this study is to find a feasible intervention that can change adverse life styles in a preconception setting. Elements from the weight loss intervention can be incorporated to the broader community, for instance as Preconception weight loss packages in the local municipalities, aimed at optimizing health before conception in the general fertile population.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI>30
  • Referred to The Fertility Clinic, Zealand Region

Exclusion criteria

  • Unable to speak and read Danish

Treatment and study plan

Systematic weight loss intervention

Behavioral

Weight reduction through life style changes in diet and exercise by the following means:

  • Counselling with a Nutritionist Nurse on diet and exercise
  • Online Smartphone coaching program (Life-sum App)
  • Motivational and adjustment dialogue and counselling with Nutritionist Nurse including anthropometric measures every month

Primary outcomes

  1. Weight loss

    Time frame: 6 month

    The change in weight (in kilograms) from baseline to the 6 month

Secondary outcomes

  1. Change in the semen quality 1

    Time frame: 6 months

    The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm count (mill/ml),

  2. Change in the semen quality 2

    Time frame: 6 months

    The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm concentration (ml)

  3. Change in the semen quality 3

    Time frame: 6 months

    The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm motility (mill/ml)

  4. Change in the semen quality 4

    Time frame: 6 months

    The change in the morphological semen parameters, from baseline to 6 month will be measured by using WHO recommendation for semen analysis: Sperm morphology (percent)

  5. Change in the DNA fragmentation index (DFI)

    Time frame: 6 months

    The change in DNA fragmentation index is measured by SPZlab using the SDI®-test

  6. Change in the vaginal microbiome

    Time frame: 6 months

    The change in the vaginal microbiome will be investigated at Statens Serum Institute (SSI), measured by PCR

  7. Change in the occurence of synthetic endocrine disruption chemicals (EDCs)

    Time frame: 6 month

    The change in the occurrence of synthetic endocrine disruption chemicals (EDCs) endometrium is measured by The Department of Growth and Reproduction at Rigshospitalet by using LC-MS/MS analyze

  8. Change in MicroRNA

    Time frame: 6 months

    The change in MicroRNA will be measured froom blood samples and is is analysed by Department of Science and Environment, RUC

  9. Change in the gene expression of gene involved in implantation

    Time frame: 6 months

    The change in the gene expression in the endometrium is analysed by Department of Science and Environment, RUC

  10. Numbers of achieved pregnancy

    Time frame: Gestational week 4-8

    Both biochemical and clinical

  11. Numbers of life births

    Time frame: From 9 month after inclusion

    Life birth

Other outcomes

  1. Blood pressure (Systolic and Diastolic)

    Time frame: 6 months

  2. Metabolic and cardiovascular marker (blood sample) 2

    Time frame: 6 months

    The change in: Hemoglobin (mmol/L

  3. Metabolic and cardiovascular marker (blood sample) 3

    Time frame: 6 months

    alanine Aminotransferase (ALT)(U/L)

  4. Metabolic and cardiovascular marker (blood sample) 4

    Time frame: 6 months

    cholesterol (mmol/L)

  5. Metabolic and cardiovascular marker (blood sample) 5

    Time frame: 6 months

    triglycerides (mmol/L)

  6. Metabolic and cardiovascular marker (blood sample) 6

    Time frame: 6 months

    HbA1c (mmol/mol (IFCC)

  7. Metabolic and cardiovascular marker (blood sample) 7

    Time frame: 6 months

    creatinine (µmol/L)

  8. Metabolic and cardiovascular marker (blood sample) 8

    Time frame: 6 months

    fasting glucose level (mmol/L (eAG))

Sponsors and collaborators

Lead sponsor

Zealand University Hospital

Other

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jan 25, 2021
Registry last updated
Jan 25, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.